Waco, TX

Allergy and Asthma Care of Waco

Urticaria

Cough

Chronic Urticaria

Chronic Cough

S-600918

Celldex Therapeutics

Shionogi

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

A Phase 3 Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

Allergy and Asthma Care of Waco | Waco, TX

Site insights

Work at this site?

Active trials

A Phase 3 Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria (EMBARQ-CSU1)

Trial sponsors